Andalusian Agency for Health Technology Assessment (AETSA) published new recommendations for hip arthroplasty in patients with osteoarthritis

30

May 2017

AETSA aimed to establish recommendations for clinical practice on hip arthroplasty in patients with osteoarthritis through a systematic appraisal of evidence.

The following recommendations were made:

  • In patients with clinical and radiologic criteria of hip osteoarthritis and who have exhausted all possibilities to control this disease with proper medical treatment conservative, hip surgery will be proposed (based on consensus Group)
  • In patients with advances stages of hip osteoarthritis is proposed as therapeutic option the total hip arthroplasty when the expected revision rate at 10 years is less than or equal to 5 % (based on the recommendations from National Institute for Health and Care Excellence)
  • To reduce the risk of complications after hip arthroplasty the use of given bearing surfaces must be based on clinical and functional needs of each patients, regardless age and gender (weak strength of recommendation)
  • The use of ceramic-ceramic bearing surfaces against metal-polyethylene to reduce osteolisys risk after hip arthroplasty at 10 years is suggested (weak strength of recommendation)
  • To reduce the ostheolisys risk in hip osteoarthritis is propose that this intervention was performed in patients with a BMI ≤ 30 kg/m2 (weak strength of recommendation)

The full document in Spanish is available here.

Subscribe to our biweekly newsletter not to miss important reimbursement information.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

24

Feb 2022

On January 18, 2022, the Ministry of Health has awarded the Framework Agreement for the acquisition of 81 linear accelerators included in the High-End Technology Equipment Investment Plan. Furthermore, the National Institute of Health Management (INGESA) has also initiated the processing of the Framework Agreement that will facilitate the acquisition of the equipment in the fields of interventional cardiology, interventional vascular radiology, interventional neurovascular, digital brachytherapy, computed tomography, magnetic resonance imaging, PET-CT, SPECT-CT.

Read more

17

Feb 2022

Since 2019, several low-cost and simple procedures in Belgium have been reimbursed not via individual INAMI fees but APR-DRG groups. This funding system is called “Low Variability Care”. On January 26, 2022, the list of APR-DRG groups and corresponding reimbursement amounts for 2022 was published.

Read more

15

Feb 2022

In January 2022, the Basque Office for Health Technology Assessment (OSTEBA) released an HTA report aiming to assess and compare the efficacy, effectiveness, and safety of the mechanical circulatory support devices most used in the healthcare setting for the treatment and prevention of cardiogenic shock, including Impella® devices, intra-aortic balloon pumps, and extracorporeal membrane oxygenation.

Read more